Nestlé Health Science announced today that it has agreed to acquire the business of IM HealthScience, a nutritional company founded in 2013 by a team of pharmaceutical research and development and management executives, specializing in medical foods nad dietary supplements.
 
IM Health Science’s products include: IBgard, a capsule-based formula for the daily dietary management of IBS; FDgard, a medical food formulated for the management of functional dyspepsia; Fiber Choice, a line of prebiotic fiber gummies which IMH added to its line through acquisition; and its latest product, REMfresh, a melatonin supplement with a patented delivery system which provides 7 hours of continuous release and absorption.
 
“The IMH products offer proven and trusted solutions for the dietary management of specific digestive problems as well as a separate solution for regulating sleep,” Greg Behar, CEO of Nestlé science, said. “IMH’s dedication to developing products to address overall health and wellness by bringing cutting-edge life science and world class research fits perfectly with our mission of empowering healthier lives through nutrition.”
 
“Science, patents, and meaningful differentiation has enabled our company to grow at several times faster than the market,” Fred Hassan, chairman and founder of IM HealthScience, said. “IBgard, FDgard, and Fiber Choice have become the number one recommended by gastroenterologists in their own segments and REMfresh is the number one sleep aid recommended by sleep specialists. The high repeat purchase rates of our four brands attest to the high patient satisfaction. We are glad that our brands have helped millions and now, under Nestlé Health Science’s able hand, millions more will benefit around the world. We are confident that under the dynamic leadership of Greg Behar, our products will keep thriving and growing.”
 
IM Health Science’s products are available both online and at retailers throughout the U.S. and Canada.